Package 71335-1044-3

{"route": ["ORAL"], "spl_id": "7c21c838-0b41-4b45-90a5-db13665c0074", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["7c46d95a-26f6-4364-8197-9e564e3405f2"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1044-1)", "package_ndc": "71335-1044-1", "marketing_start_date": "20190103"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1044-2)", "package_ndc": "71335-1044-2", "marketing_start_date": "20200610"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1044-3)", "package_ndc": "71335-1044-3", "marketing_start_date": "20190228"}, {"sample": false, "description": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1044-4)", "package_ndc": "71335-1044-4", "marketing_start_date": "20211228"}, {"sample": false, "description": "14 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1044-5)", "package_ndc": "71335-1044-5", "marketing_start_date": "20211228"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "71335-1044_7c21c838-0b41-4b45-90a5-db13665c0074", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "71335-1044", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA210497", "marketing_category": "ANDA", "marketing_start_date": "20181108", "listing_expiration_date": "20261231"}